Literature DB >> 12410098

Phototherapy for scleroderma: biologic rationale, results, and promise.

Gary J Fisher1, Sewon Kang.   

Abstract

Scleroderma is a chronic disease of connective tissue characterized by deposition of large amounts of collagen. Localized scleroderma affects only the skin, whereas systemic disease, systemic sclerosis, may affect the lungs, gastrointestinal tract, kidneys, and heart in addition to the skin. Although the various forms of localized scleroderma are not life threatening, they result in considerable morbidity owing to joint contracture, loss of flexibility, and disfigurement. Although many different treatments have been attempted, until now none has proven to be effective. Accumulating evidence indicates that UVA irradiation offers a genuine opportunity to ameliorate localized scleroderma and the cutaneous manifestations of systemic sclerosis.

Entities:  

Mesh:

Year:  2002        PMID: 12410098     DOI: 10.1097/00002281-200211000-00016

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  6 in total

Review 1.  Systemic and localized scleroderma in children: current and future treatment options.

Authors:  Margalit E Rosenkranz; Lucila M A Agle; Petros Efthimiou; Thomas J A Lehman
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

2.  Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy.

Authors:  Frank Wang; Luis A Garza; Soyun Cho; Reza Kafi; Craig Hammerberg; Taihao Quan; Ted Hamilton; Maureen Mayes; Voravit Ratanatharathorn; John J Voorhees; Gary J Fisher; Sewon Kang
Journal:  Arch Dermatol       Date:  2008-07

3.  Dermal damage promoted by repeated low-level UV-A1 exposure despite tanning response in human skin.

Authors:  Frank Wang; Noah R Smith; Bao Anh Patrick Tran; Sewon Kang; John J Voorhees; Gary J Fisher
Journal:  JAMA Dermatol       Date:  2014-04       Impact factor: 10.282

4.  The use of streptolysin o for the treatment of scars, adhesions and fibrosis: initial investigations using murine models of scleroderma.

Authors:  Stephen W Mamber; Vit Long; Ryan G Rhodes; Sunthorn Pond-Tor; Lyn R Wheeler; Kellie Fredericks; Brian Vanscoy; Jean-Frederic Sauniere; Remy Steinschneider; Jean-Claude Laurent; John McMichael
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-04

5.  Fractional carbon dioxide laser versus low-dose UVA-1 phototherapy for treatment of localized scleroderma: a clinical and immunohistochemical randomized controlled study.

Authors:  S M Shalaby; M Bosseila; M M Fawzy; D M Abdel Halim; S S Sayed; R S H M Allam
Journal:  Lasers Med Sci       Date:  2016-08-10       Impact factor: 3.161

Review 6.  UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review.

Authors:  Frank Breuckmann; Thilo Gambichler; Peter Altmeyer; Alexander Kreuter
Journal:  BMC Dermatol       Date:  2004-09-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.